ClinVar Miner

Submissions for variant NM_004208.4(AIFM1):c.1030C>T (p.Leu344Phe)

gnomAD frequency: 0.00004  dbSNP: rs184474885
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000868580 SCV001009925 benign Charcot-Marie-Tooth Neuropathy X; Combined oxidative phosphorylation deficiency 2024-02-24 criteria provided, single submitter clinical testing
GeneDx RCV002051816 SCV002319081 uncertain significance not provided 2024-09-25 criteria provided, single submitter clinical testing Identified as heterozygous in several unrelated Chinese females with bilateral auditory neuropathy in published literature, and in one female with unilateral auditory neuropathy, suggesting possible X-linked dominant inheritance (PMID: 34175691, 32684920); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in 37/14851 (0.2491%) alleles from individuals of East Asian background in large population cohorts (gnomAD); unknown if this represents a pathogenic founder variant or a common benign variant in this population; This variant is associated with the following publications: (PMID: 31832524, Chai_2021_Editorial, 34175691, 32684920, 25986071, 35578252)
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV002051816 SCV005878152 uncertain significance not provided 2024-04-16 criteria provided, single submitter clinical testing The AIFM1 c.1030C>T; p.Leu344Phe variant (rs184474885, ClinVar Variation ID: 162477) is reported in the literature in individuals affected with auditory neuropathy, including affected heterozygous female patients (Song 2021, Wang 2020, Zong 2015). Additionally, this variant was found in an individual affected with Charcot-Marie-Tooth disease-4 (Chen 2022), and in an infant with focal seizures (Ma 2019). This variant is found in the East Asian population with an allele frequency of 0.25% (37/14,851 alleles, including 20 hemizygotes) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.279). Due to conflicting information, the clinical significance of this variant is uncertain at this time. References: Chen J et al. Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations. BMC Neurol. 2022 May 16;22(1):180. PMID: 35578252. Ma X et al. Genetic diagnosis of neonatal-onset seizures. Genes Dis. 2019 Feb 8;6(4):441-447. PMID: 31832524. Song M et al. Clinical characteristics of patients with unilateral auditory neuropathy. Am J Otolaryngol. 2021 Sep-Oct;42(5):103143. PMID: 34175691. Wang H et al. High Frequency of AIFM1 Variants and Phenotype Progression of Auditory Neuropathy in a Chinese Population. Neural Plast. 2020 Jul 1;2020:5625768. PMID: 32684920. Zong L et al. Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder. J Med Genet. 2015 Aug;52(8):523-31. PMID: 25986071.
Deafness Gene Diagnosis, Xijing Hospital RCV000149862 SCV000196716 likely pathogenic Deafness, X-linked 5 no assertion criteria provided clinical testing
OMIM RCV000149862 SCV000257353 pathogenic Deafness, X-linked 5 2015-08-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.